alkeran tablets film-coated
excella gmbh & co.kg - melphalan - tablets film-coated - 2mg
alkeran tablet
aspen pharmacare canada inc. - melphalan - tablet - 2mg - melphalan 2mg - antineoplastic agents
alkeran- melphalan hydrochloride kit
apopharma usa, inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan 50 mg in 10 ml - alkeran for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.
alkeran 2mg tablets
aspen pharma trading ltd - melphalan - oral tablet - 2mg
melphalan tablet, film coated 2mg
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - melphalan - film-coated tablet - melphalan - antineoplastic agents
alkeran tablets 2 mg film-coated tablet
glaxowellcome - melphalan - film-coated tablet - 2 mg
alkeran tablets 2 mg film-coated tablet
aspen pharma trading limited (aptl), ireland - melphalan - film-coated tablet - 2 mg
alkeran tablets 2 mg film-coated tablet
aspen - melphalan - film-coated tablet - 2 mg
melphalan hydrochloride kit
athenex pharmaceutical division, llc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.
melphalan hydrochloride kit
avenacy inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.